136 related articles for article (PubMed ID: 9557957)
1. Oral administration of one dose of cholera toxin induces a systemic immune response prior to a mucosal immune response by a direct presentation in the spleen.
Benedetti R; Lev P; Massouh E; Fló J
Immunol Lett; 1998 Feb; 60(2-3):149-56. PubMed ID: 9557957
[TBL] [Abstract][Full Text] [Related]
2. The bone marrow as a site of antibody production after a mucosal immunization.
Benedetti R; Massouh E; Fló J
Immunol Lett; 1995 Dec; 48(2):109-15. PubMed ID: 8719108
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.
Lycke N; Holmgren J
Infect Immun; 1989 Apr; 57(4):1137-41. PubMed ID: 2784416
[TBL] [Abstract][Full Text] [Related]
4. Reversible effects on B and T cells of the gut-associated lymphoid tissues in rats malnourished during suckling: impaired induction of the immune response to intra-Peyer patches immunization with cholera toxin.
Fló J; Elías F; Benedetti R; Massouh E
Clin Immunol Immunopathol; 1996 Aug; 80(2):147-54. PubMed ID: 8764559
[TBL] [Abstract][Full Text] [Related]
5. IgA isotype restriction in the mucosal but not in the extramucosal immune response after oral immunizations with cholera toxin or cholera B subunit.
Lycke N; Lindholm L; Holmgren J
Int Arch Allergy Appl Immunol; 1983; 72(2):119-27. PubMed ID: 6874106
[TBL] [Abstract][Full Text] [Related]
6. Long-term antibodies after an oral immunization with cholera toxin are synthesized in the bone marrow and may play a role in the regulation of memory B-cell maintenance at systemic and mucosal sites.
Benedetti R; Lev P; Massouh E; Fló J
Res Immunol; 1998 Feb; 149(2):107-18. PubMed ID: 9628392
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
Vajdy M; Lycke N
Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
[TBL] [Abstract][Full Text] [Related]
8. Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin.
Lycke N; Holmgren J
Scand J Immunol; 1986 May; 23(5):611-6. PubMed ID: 3704560
[TBL] [Abstract][Full Text] [Related]
9. Deficient induction of the immune response to oral immunization with cholera toxin in malnourished rats during suckling.
Fló J; Roux ME; Massouh E
Infect Immun; 1994 Nov; 62(11):4948-54. PubMed ID: 7927775
[TBL] [Abstract][Full Text] [Related]
10. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
Elson CO; Ealding W
J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
[TBL] [Abstract][Full Text] [Related]
11. Anti-cholera toxin IgA-, IgG- and IgM-secreting cells in various rat lymphoid tissues after repeated intestinal or parenteral immunizations.
Solbreux PM; Dive C; Vaerman JP
Immunol Invest; 1990; 19(5-6):435-51. PubMed ID: 2074113
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of a bacterial immunomodulator enhances the immune response to cholera toxin.
Fló J; Goldman H; Roux ME; Massouh E
Vaccine; 1996 Aug; 14(12):1167-73. PubMed ID: 8911015
[TBL] [Abstract][Full Text] [Related]
13. Host defense against cholera toxin is strongly CD4+ T cell dependent.
Hörnqvist E; Goldschmidt TJ; Holmdahl R; Lycke N
Infect Immun; 1991 Oct; 59(10):3630-8. PubMed ID: 1910010
[TBL] [Abstract][Full Text] [Related]
14. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of aging on B-cell immune responses to cholera toxin in the inductive and effector sites of the mucosal immune system.
Haq JA; Szewczuk MR
Infect Immun; 1991 Sep; 59(9):3094-100. PubMed ID: 1879933
[TBL] [Abstract][Full Text] [Related]
16. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.
Koster FT; Pierce NF
J Immunol; 1983 Jul; 131(1):115-9. PubMed ID: 6190901
[TBL] [Abstract][Full Text] [Related]
17. Intestinal immunization with soluble bacterial antigens: the example of cholera toxoid.
Pierce NF
Ciba Found Symp; 1976; (42):129-47. PubMed ID: 1086763
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
19. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant.
Wilson AD; Bailey M; Williams NA; Stokes CR
Eur J Immunol; 1991 Oct; 21(10):2333-9. PubMed ID: 1833201
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.
Pierce NF; Cray WC; Sacci JB
Infect Immun; 1982 Aug; 37(2):687-94. PubMed ID: 6889574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
